APA (7th ed.) Citation

Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor Cahill, Richard de Rooij, . . . Jeanne-Marie Jacquet. (2021). Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: A phase 1 randomized controlled trial in adults. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor Cahill, Richard de Rooij, Martin Struijs, Hester van Zeeburg, and Jeanne-Marie Jacquet. Safety and Immunogenicity of a New Sabin Inactivated Poliovirus Vaccine Candidate Produced on the PER.C6® Cell-line: A Phase 1 Randomized Controlled Trial in Adults. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Isabel Leroux-Roels, et al. Safety and Immunogenicity of a New Sabin Inactivated Poliovirus Vaccine Candidate Produced on the PER.C6® Cell-line: A Phase 1 Randomized Controlled Trial in Adults. Taylor & Francis Group, 2021.